Medicines pricing often dominates the conversation about the pharmaceutical industry, shaping public perception and influencing trust. Yet much of the sector’s real contribution, to patients, the NHS, and system sustainability, sits beyond price and is less visible in everyday debate. Making that wider value clear, credible, and relevant is an ongoing challenge. How can we, as communicators, help make pharma’s value beyond pricing more visible and better understood?